Selected research
Industry Growth & Trends
Global DNA Gyrase Subunit B (EC 5.99.1.3) Industry Growth and Trends Forecast to 2032
Market perspective
According to APO Research, the global DNA Gyrase Subunit B (EC 5.99.1.3) market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.
The North America market for DNA Gyrase Subunit B (EC 5.99.1.3) is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.
The Europe market for DNA Gyrase Subunit B (EC 5.99.1.3) is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.
Read the full market overview
The Asia Pacific market for DNA Gyrase Subunit B (EC 5.99.1.3) is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Leading global companies in the DNA Gyrase Subunit B (EC 5.99.1.3) market include Merck & Co., Inc., AstraZeneca Plc, Daiichi Sankyo Company Ltd and Abgentis Limited, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
This report provides a structured, data-driven view of the global DNA Gyrase Subunit B (EC 5.99.1.3) market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.
The DNA Gyrase Subunit B (EC 5.99.1.3) market size, estimates, and forecasts are presented in terms of revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global DNA Gyrase Subunit B (EC 5.99.1.3) market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to DNA Gyrase Subunit B (EC 5.99.1.3).
Key Companies & Market Share Insights
This section analyzes the strategies and performance of leading companies in the global DNA Gyrase Subunit B (EC 5.99.1.3) market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue and gross margin data by manufacturer for 2021-2026, enabling benchmarking of scale, profitability, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.
DNA Gyrase Subunit B (EC 5.99.1.3) Market by Company
Merck & Co., Inc.
AstraZeneca Plc
Daiichi Sankyo Company Ltd
Abgentis Limited
DNA Gyrase Subunit B (EC 5.99.1.3) Segment by Type
VXC-100
VT-12008911
GYR-12
DS-2969
Others
DNA Gyrase Subunit B (EC 5.99.1.3) Segment by Application
Bacterial Infections
Clostridium Diffclie Infections
Klebsiella Pneumoniae Infections
Others
DNA Gyrase Subunit B (EC 5.99.1.3) Segment by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Netherlands
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
South America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global DNA Gyrase Subunit B (EC 5.99.1.3) market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of DNA Gyrase Subunit B (EC 5.99.1.3) and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of DNA Gyrase Subunit B (EC 5.99.1.3).
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2021-2025, 2026-2031). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 3: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 4: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 5: Detailed analysis of DNA Gyrase Subunit B (EC 5.99.1.3) companies' competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.
Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, revenue by country.
Chapter 12: Concluding Insights of the report
More report detail
Tables and figures
Scope & coverage.
Types
- VXC-100
- VT-12008911
- GYR-12
- DS-2969
- Others
Applications
- Bacterial Infections
- Clostridium Diffclie Infections
- Klebsiella Pneumoniae Infections
- Others
Companies covered
- Merck & Co., Inc.
- AstraZeneca Plc
- Daiichi Sankyo Company Ltd
- Abgentis Limited
Inside the report.
1 Market Overview
- 1.1 Product Definition
- 1.2 Global Market Growth Prospects
- 1.3 Global DNA Gyrase Subunit B (EC 5.99.1.3) Market Size Overview by Region 2021 VS 2025 VS 2032
- 1.4 Global DNA Gyrase Subunit B (EC 5.99.1.3) Market Size by Region (2021-2032)
- 1.4.1 Global DNA Gyrase Subunit B (EC 5.99.1.3) Market Size by Region (2021-2026)
- 1.4.2 Global DNA Gyrase Subunit B (EC 5.99.1.3) Market Size by Region (2027-2032)
- 1.5 Key Regions DNA Gyrase Subunit B (EC 5.99.1.3) Market Size (2021-2032)
- 1.5.1 North America DNA Gyrase Subunit B (EC 5.99.1.3) Market Size Growth Rate (2021-2032)
- 1.5.2 Europe DNA Gyrase Subunit B (EC 5.99.1.3) Market Size Growth Rate (2021-2032)
- 1.5.3 Asia-Pacific DNA Gyrase Subunit B (EC 5.99.1.3) Market Size Growth Rate (2021-2032)
- 1.5.4 South America DNA Gyrase Subunit B (EC 5.99.1.3) Market Size Growth Rate (2021-2032)
- 1.5.5 Middle East & Africa DNA Gyrase Subunit B (EC 5.99.1.3) Market Size Growth Rate (2021-2032)
2 DNA Gyrase Subunit B (EC 5.99.1.3) Market by Type
- 2.1 Type Introduction
- 2.1.1 VXC-100
- 2.1.2 VT-12008911
- 2.1.3 GYR-12
- 2.1.4 DS-2969
- 2.1.5 Others
- 2.2 Global DNA Gyrase Subunit B (EC 5.99.1.3) Market Size by Type
- 2.2.1 Global DNA Gyrase Subunit B (EC 5.99.1.3) Market Size Overview by Type (2021-2032)
- 2.2.2 Global DNA Gyrase Subunit B (EC 5.99.1.3) Historic Market Size Review by Type (2021-2026)
- 2.2.3 Global DNA Gyrase Subunit B (EC 5.99.1.3) Market Size Forecasted by Type (2027-2032)
- 2.3 Global DNA Gyrase Subunit B (EC 5.99.1.3) Market Size by Regions
- 2.3.1 North America DNA Gyrase Subunit B (EC 5.99.1.3) Market Size Breakdown by Type (2021-2026)
- 2.3.2 Europe DNA Gyrase Subunit B (EC 5.99.1.3) Market Size Breakdown by Type (2021-2026)
- 2.3.3 Asia-Pacific DNA Gyrase Subunit B (EC 5.99.1.3) Market Size Breakdown by Type (2021-2026)
- 2.3.4 South America DNA Gyrase Subunit B (EC 5.99.1.3) Market Size Breakdown by Type (2021-2026)
- 2.3.5 Middle East and Africa DNA Gyrase Subunit B (EC 5.99.1.3) Market Size Breakdown by Type (2021-2026)
3 DNA Gyrase Subunit B (EC 5.99.1.3) Market by Application
- 3.1 Type Introduction
- 3.1.1 Bacterial Infections
- 3.1.2 Clostridium Diffclie Infections
- 3.1.3 Klebsiella Pneumoniae Infections
- 3.1.4 Others
- 3.2 Global DNA Gyrase Subunit B (EC 5.99.1.3) Market Size by Application
- 3.2.1 Global DNA Gyrase Subunit B (EC 5.99.1.3) Market Size Overview by Application (2021-2032)
- 3.2.2 Global DNA Gyrase Subunit B (EC 5.99.1.3) Historic Market Size Review by Application (2021-2026)
- 3.2.3 Global DNA Gyrase Subunit B (EC 5.99.1.3) Market Size Forecasted by Application (2027-2032)
- 3.3 Global DNA Gyrase Subunit B (EC 5.99.1.3) Market Size by Regions
- 3.3.1 North America DNA Gyrase Subunit B (EC 5.99.1.3) Market Size Breakdown by Application (2021-2026)
- 3.3.2 Europe DNA Gyrase Subunit B (EC 5.99.1.3) Market Size Breakdown by Application (2021-2026)
- 3.3.3 Asia-Pacific DNA Gyrase Subunit B (EC 5.99.1.3) Market Size Breakdown by Application (2021-2026)
- 3.3.4 South America DNA Gyrase Subunit B (EC 5.99.1.3) Market Size Breakdown by Application (2021-2026)
- 3.3.5 Middle East and Africa DNA Gyrase Subunit B (EC 5.99.1.3) Market Size Breakdown by Application (2021-2026)
4 Global Market Dynamics
- 4.1 DNA Gyrase Subunit B (EC 5.99.1.3) Industry Trends
- 4.2 DNA Gyrase Subunit B (EC 5.99.1.3) Industry Drivers
- 4.3 DNA Gyrase Subunit B (EC 5.99.1.3) Industry Opportunities and Challenges
- 4.4 DNA Gyrase Subunit B (EC 5.99.1.3) Industry Restraints
5 Competitive Insights by Company
- 5.1 Global Top Players by DNA Gyrase Subunit B (EC 5.99.1.3) Revenue (2021-2026)
- 5.2 Global DNA Gyrase Subunit B (EC 5.99.1.3) Industry Company Ranking, 2024 VS 2025 VS 2026
- 5.3 Global DNA Gyrase Subunit B (EC 5.99.1.3) Key Company Headquarters & Area Served
- 5.4 Global DNA Gyrase Subunit B (EC 5.99.1.3) Company, Product Type & Application
- 5.5 Global DNA Gyrase Subunit B (EC 5.99.1.3) Company Commercialization Time
- 5.6 Market Competitive Analysis
- 5.6.1 Global DNA Gyrase Subunit B (EC 5.99.1.3) Market CR5 and HHI
- 5.6.2 Global Top 5 and 10 DNA Gyrase Subunit B (EC 5.99.1.3) Players Market Share by Revenue in 2025
- 5.6.3 2025 DNA Gyrase Subunit B (EC 5.99.1.3) Tier 1, Tier 2, and Tier 3
6 Company Profiles
- 6.1 Merck & Co., Inc.
- 6.1.1 Merck & Co., Inc. Company Information
- 6.1.2 Merck & Co., Inc. Business Overview
- 6.1.3 Merck & Co., Inc. DNA Gyrase Subunit B (EC 5.99.1.3) Revenue, Global Share and Gross Margin (2021-2026)
- 6.1.4 Merck & Co., Inc. DNA Gyrase Subunit B (EC 5.99.1.3) Product Portfolio
- 6.1.5 Merck & Co., Inc. Recent Developments
- 6.2 AstraZeneca Plc
- 6.2.1 AstraZeneca Plc Company Information
- 6.2.2 AstraZeneca Plc Business Overview
- 6.2.3 AstraZeneca Plc DNA Gyrase Subunit B (EC 5.99.1.3) Revenue, Global Share and Gross Margin (2021-2026)
- 6.2.4 AstraZeneca Plc DNA Gyrase Subunit B (EC 5.99.1.3) Product Portfolio
- 6.2.5 AstraZeneca Plc Recent Developments
- 6.3 Daiichi Sankyo Company Ltd
- 6.3.1 Daiichi Sankyo Company Ltd Company Information
- 6.3.2 Daiichi Sankyo Company Ltd Business Overview
- 6.3.3 Daiichi Sankyo Company Ltd DNA Gyrase Subunit B (EC 5.99.1.3) Revenue, Global Share and Gross Margin (2021-2026)
- 6.3.4 Daiichi Sankyo Company Ltd DNA Gyrase Subunit B (EC 5.99.1.3) Product Portfolio
- 6.3.5 Daiichi Sankyo Company Ltd Recent Developments
- 6.4 Abgentis Limited
- 6.4.1 Abgentis Limited Company Information
- 6.4.2 Abgentis Limited Business Overview
- 6.4.3 Abgentis Limited DNA Gyrase Subunit B (EC 5.99.1.3) Revenue, Global Share and Gross Margin (2021-2026)
- 6.4.4 Abgentis Limited DNA Gyrase Subunit B (EC 5.99.1.3) Product Portfolio
- 6.4.5 Abgentis Limited Recent Developments
7 North America
- 7.1 North America DNA Gyrase Subunit B (EC 5.99.1.3) Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 7.2 North America DNA Gyrase Subunit B (EC 5.99.1.3) Market Size by Country (2021-2026)
- 7.3 North America DNA Gyrase Subunit B (EC 5.99.1.3) Market Size Forecast by Country (2027-2032)
8 Europe
- 8.1 Europe DNA Gyrase Subunit B (EC 5.99.1.3) Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 8.2 Europe DNA Gyrase Subunit B (EC 5.99.1.3) Market Size by Country (2021-2026)
- 8.3 Europe DNA Gyrase Subunit B (EC 5.99.1.3) Market Size Forecast by Country (2027-2032)
9 Asia-Pacific
- 9.1 Asia-Pacific DNA Gyrase Subunit B (EC 5.99.1.3) Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 9.2 Asia-Pacific DNA Gyrase Subunit B (EC 5.99.1.3) Market Size by Country (2021-2026)
- 9.3 Asia-Pacific DNA Gyrase Subunit B (EC 5.99.1.3) Market Size Forecast by Country (2027-2032)
10 South America
- 10.1 South America DNA Gyrase Subunit B (EC 5.99.1.3) Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 10.2 South America DNA Gyrase Subunit B (EC 5.99.1.3) Market Size by Country (2021-2026)
- 10.3 South America DNA Gyrase Subunit B (EC 5.99.1.3) Market Size Forecast by Country (2027-2032)
11 Middle East & Africa
- 11.1 Middle East & Africa DNA Gyrase Subunit B (EC 5.99.1.3) Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 11.2 Middle East & Africa DNA Gyrase Subunit B (EC 5.99.1.3) Market Size by Country (2021-2026)
- 11.3 Middle East & Africa DNA Gyrase Subunit B (EC 5.99.1.3) Market Size Forecast by Country (2027-2032)
12 Concluding Insights
13 Appendix
- 13.1 Reasons for Doing This Study
- 13.2 Research Methodology
- 13.3 Research Process
- 13.4 Authors List of This Report
- 13.5 Data Source
- 13.5.1 Secondary Sources
- 13.5.2 Primary Sources
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst